G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL

Blood Adv. 2022 Jun 14;6(11):3255-3259. doi: 10.1182/bloodadvances.2021004854.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • Humans
  • Leukemia* / drug therapy
  • RNA-Binding Proteins

Substances

  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • G3BP2 protein, human
  • RNA-Binding Proteins